SCHEMBL20055153

SCHEMBL20055153

CCN1CCN(C)CC1C(C)C

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CALCA P06881 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27375838 1.00 CALCA (0.35) CALCA
SCHEMBL14328681 0.93 CALCA (0.33) CALCA
SCHEMBL14328679 0.83 CALCA (0.30) CALCA
SCHEMBL14328690 0.83 CALCA (0.30) CALCA
SCHEMBL23735871 0.82
SCHEMBL27281658 0.82 PIK3CD (0.33) CALCA
SCHEMBL28894727 0.81
SCHEMBL27284741 0.79 CALCA (0.33) CALCA
SCHEMBL22309124 0.78
SCHEMBL14328682 0.78 HSD11B1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081311-A1 CBL-B MODULATORS AND USES THEREOF NIMBUS CLIO, INC. (US) 2024-04-18 WO disclosed
WO-2024020034-A1 CBL-B INHIBITORS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2024-01-25 WO disclosed
WO-2023072273-A1 POLYCYCLIC COMPOUND AS CBL-B INHIBITOR 先声再明医药有限公司 2023-05-04 WO disclosed
EP-3309157-A1 ANTIVIRAL COMPOUNDS Gilead Pharmasset LLC (US) 2018-04-18 EP disclosed